Mind the Gap: Women’s Health

Inside the Venture Studio Actually Solving Women's Health Problems

1 h 8 min · I går
episode Inside the Venture Studio Actually Solving Women's Health Problems cover

Beskrivelse

Investment & Innovation: Building the FemTech Pipeline with Malin Frithiofsson, CEO of Daya Ventures Only 2% of venture capital goes to all-female founding teams. In this episode, Malin Frithiofsson, CEO of Daya Ventures, breaks down how a venture studio model is closing that gap, building FemTech startups from the ground up, de-risking innovation, and putting ownership back in women's hands. We cover: the funding gap behind the research gap, why "FemTech" needs a real definition, autoimmune disease and occupational health as the next frontiers, and what it actually takes to pitch women's health to investors who only speak the language of returns.

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av Mind the Gap: Women’s Health sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden. · Avslutt når som helst.

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

12 Episoder

episode Why Women's Health Is Actually the Smartest Investment Right Now cover

Why Women's Health Is Actually the Smartest Investment Right Now

Vasanta Pundarika is the CEO and founder of Lotuspring, a healthcare advisory firm helping visionary leaders in women's health and behavioural health build sustainable growth strategies. With 20 years of experience as a healthcare investment banker, she has advised on transactions ranging from early-stage startups to multi-billion dollar companies. Vasanta breaks down why heart disease, not breast cancer, is the number one killer of women, and why so few people know it. She unpacks the real mechanics of fundraising in women's health: what investors actually look for, why founders are exhausted from explaining their sector before they even get to their pitch, and what it truly takes to build a women's health company that lasts. Clear-eyed, financially fluent, and deeply grounded in clinical reality this one is essential listening whether you are a founder, an investor, or simply trying to understand why this space is still struggling to scale.

26. mai 202636 min